ClinicalTrials.govpublic full text
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
ovarian cancer, fallopian tube neoplasms, peritoneal neoplasms, aca 125, 6 or 9 vaccinations, immune response, fallopian tube cancer, peritoneal cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848731
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.